Literature DB >> 19444586

Localized cervical cancer (stage <IIB): accuracy of MR imaging in planning less extensive surgery.

R Manfredi1, B Gui, A Giovanzana, S Marini, M Di Stefano, G Zannoni, G Scambia, L Bonomo.   

Abstract

PURPOSE: This study was undertaken to determine the accuracy of magnetic resonance (MR) imaging in the preoperative staging of patients with clinically localised cervical cancer eligible for less extensive surgery.
MATERIALS AND METHODS: Fifty-three patients with biopsy-proven carcinoma of the uterine cervix and eligible for conservative surgery prospectively underwent MR imaging. Images were assessed for tumour site and size, infiltration of the cervical stroma, infiltration of vaginal fornices and relationship between the tumour and the internal os of the endocervical canal and the presence and dimensions of pelvic and lumboaortic lymph nodes (cutoff values 1 cm and 0.5 cm minimum axial diameter). MR imaging data were compared with the histopathological findings.
RESULTS: The endocervix was the site of origin of 25% (13/53) of the cervical tumours and the exocervix the site of origin of 75% (40/53). In the assessment of cervical stroma infiltration, there was agreement between MR imaging and histopathology in 75% of cases. MR imaging had 67% sensitivity, 92% specificity and 91% diagnostic accuracy in assessing infiltration of the vaginal fornices. In the evaluation of the infiltration of the internal os, MR imaging had 86% sensitivity, 93% specificity and 92% accuracy. In the assessment of the lymph nodes, when using a cutoff value of 1 cm, MR imaging had a sensitivity, specificity and diagnostic accuracy of 28%, 100% and 89%, respectively. With a cutoff value of 0.5 cm, MR imaging had a sensitivity, specificity and diagnostic accuracy of 33%, 92% and 83%, respectively.
CONCLUSIONS: MR imaging had a high level of accuracy in the preoperative assessment of the extent of cervical tumour in patients eligible for conservative surgery. Accuracy is lower in the evaluation of the pelvic and lumboaortic lymph nodes.

Entities:  

Mesh:

Year:  2009        PMID: 19444586     DOI: 10.1007/s11547-009-0397-3

Source DB:  PubMed          Journal:  Radiol Med        ISSN: 0033-8362            Impact factor:   3.469


  30 in total

1.  Pelvic lymph node visualization with MR imaging using local administration of ultra-small superparamagnetic iron oxide contrast.

Authors:  Thomas R McCauley; Matthew D Rifkin; Cheryl A Ledet
Journal:  J Magn Reson Imaging       Date:  2002-04       Impact factor: 4.813

2.  MR imaging in cervical cancer: seeing is believing. The 2004 Mackenzie Davidson Memorial Lecture.

Authors:  R H Reznek; A Sahdev
Journal:  Br J Radiol       Date:  2005       Impact factor: 3.039

3.  Early cervical carcinoma: the natural history of lymph node involvement redefined on the basis of thorough parametrectomy and giant section study.

Authors:  P Benedetti-Panici; F Maneschi; G D'Andrea; G Cutillo; C Rabitti; M Congiu; F Coronetta; A Capelli
Journal:  Cancer       Date:  2000-05-15       Impact factor: 6.860

4.  Radical hysterectomy: a randomized study comparing two techniques for resection of the cardinal ligament.

Authors:  P Benedetti-Panici; G Scambia; G Baiocchi; F Maneschi; S Greggi; S Mancuso
Journal:  Gynecol Oncol       Date:  1993-08       Impact factor: 5.482

5.  Five classes of extended hysterectomy for women with cervical cancer.

Authors:  M S Piver; F Rutledge; J P Smith
Journal:  Obstet Gynecol       Date:  1974-08       Impact factor: 7.661

6.  MR imaging appearances of the female pelvis after trachelectomy.

Authors:  Anju Sahdev; Jonathan Jones; John H Shepherd; Rodney H Reznek
Journal:  Radiographics       Date:  2005 Jan-Feb       Impact factor: 5.333

7.  Invasive cervical carcinoma: comparison of MR imaging and surgical findings.

Authors:  H Hricak; C G Lacey; L G Sandles; Y C Chang; M L Winkler; J L Stern
Journal:  Radiology       Date:  1988-03       Impact factor: 11.105

8.  Carcinoma of the cervix: staging with MR imaging.

Authors:  K Togashi; K Nishimura; T Sagoh; S Minami; S Noma; I Fujisawa; Y Nakano; J Konishi; H Ozasa; I Konishi
Journal:  Radiology       Date:  1989-04       Impact factor: 11.105

Review 9.  Imaging of cancer of the cervix.

Authors:  Juergen Scheidler; Andreas F Heuck
Journal:  Radiol Clin North Am       Date:  2002-05       Impact factor: 2.303

Review 10.  Surgical aspects of cervical carcinoma.

Authors:  P J DiSaia
Journal:  Cancer       Date:  1981-07-15       Impact factor: 6.860

View more
  5 in total

1.  Is MRI helpful in assessing the distance of the tumour from the internal os in patients with cervical cancer below FIGO Stage IB2?

Authors:  P R Bhosale; R B Iyer; P Ramalingam; K M Schmeler; W Wei; R L Bassett; P T Ramirez; M Frumovitz
Journal:  Clin Radiol       Date:  2016-03-21       Impact factor: 2.350

2.  Diffusion-weighted MR imaging in assessing cervical tumour response to nonsurgical therapy.

Authors:  S Rizzo; P Summers; S Raimondi; M Belmonte; M Maniglio; F Landoni; N Colombo; M Bellomi
Journal:  Radiol Med       Date:  2011-03-07       Impact factor: 3.469

3.  Comparison of imaging-based gross tumor volume and pathological volume determined by whole-mount serial sections in primary cervical cancer.

Authors:  Ying Zhang; Jing Hu; Jianping Li; Ning Wang; Weiwei Li; Yongchun Zhou; Junyue Liu; Lichun Wei; Mei Shi; Shengjun Wang; Jing Wang; Xia Li; Wanling Ma
Journal:  Onco Targets Ther       Date:  2013-07-19       Impact factor: 4.147

Review 4.  The value of advanced MRI techniques in the assessment of cervical cancer: a review.

Authors:  Evelyn Dappa; Tania Elger; Annette Hasenburg; Christoph Düber; Marco J Battista; Andreas M Hötker
Journal:  Insights Imaging       Date:  2017-08-21

5.  Craniocaudal tumour extension in uterine cervical cancer on MRI compared to histopathology.

Authors:  Peter de Boer; Maaike C G Bleeker; Anje M Spijkerboer; Agustinus J A J van de Schoot; Shandra Bipat; Marrije R Buist; Coen R N Rasch; Jaap Stoker; Lukas J A Stalpers
Journal:  Eur J Radiol Open       Date:  2015-07-26
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.